The location of premalignant colorectal polyps under age 50: a further rationale for screening sigmoidoscopy.


Journal

International journal of colorectal disease
ISSN: 1432-1262
Titre abrégé: Int J Colorectal Dis
Pays: Germany
ID NLM: 8607899

Informations de publication

Date de publication:
Mar 2020
Historique:
accepted: 08 01 2020
pubmed: 14 1 2020
medline: 20 11 2020
entrez: 14 1 2020
Statut: ppublish

Résumé

The incidence of colorectal cancer (CRC) among young adults has been dramatically rising, with guidelines for screening recently adjusted to start at age 45. However, knowledge of the precursor lesions is limited. We recently reported that 83% of CRC diagnosed under age 50 are left sided. Our aim was to analyze the location and histology of benign colorectal lesions found in a cohort of patients younger than 50, documenting the presence of advanced histology. We used the database in the Department of Pathology to retrospectively review the location and histology of all benign colorectal neoplasms in patients under age 50 submitted to pathology examination during 2006-2016. A total of 8364 lesions were examined from 4773 patients, and 3534 (65.5%) of the patients had only one polyp and the rest had multiple. Mean age was 41.9 years (range 16-49) while 3843 (72.8%) of the patients were between the ages of 40 and 49. In total, 4570/8364 lesions (54.6%) were distal to the splenic flexure. The most common pathology was tubular adenoma (63.7%), then hyperplastic polyps (16.6%), sessile serrated lesions (SSLs) (13.1%), and tubulovillous adenomas (6.3%). Tubulovillous adenomas, villous lesions, advanced adenomas, and adenomas with high-grade dysplasia were all predominantly left sided (left colon and rectum = 77.6%, 85%, 78.3%, and 87.6% respectively). Of the SSLs, 71.5% were in the right colon while 16.6% of hyperplastic lesions were right sided. High-risk advanced adenomas are predominantly left sided. This focuses attention on the rectum and left colon where carcinogenesis is strong in the young.

Identifiants

pubmed: 31930456
doi: 10.1007/s00384-020-03504-2
pii: 10.1007/s00384-020-03504-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

529-535

Références

Science. 2015 Jan 2;347(6217):78-81
pubmed: 25554788
Am J Gastroenterol. 2006 Feb;101(2):255-62
pubmed: 16454827
N Engl J Med. 2002 Jun 6;346(23):1781-5
pubmed: 12050337
CA Cancer J Clin. 2018 Jul;68(4):250-281
pubmed: 29846947
Lancet. 2017 Apr 1;389(10076):1299-1311
pubmed: 28236467
Dis Colon Rectum. 2019 Jan;62(1):21-26
pubmed: 30394984
J Clin Med. 2018 Jan 30;7(2):
pubmed: 29385768
Int J Colorectal Dis. 2015 Dec;30(12):1653-7
pubmed: 26358068
Am J Surg Pathol. 2011 Sep;35(9):1274-86
pubmed: 21836485
Gastroenterology. 2008 May;134(5):1311-5
pubmed: 18471508
JAMA. 2012 Aug 1;308(5):485-492
pubmed: 22851115
J Gastroenterol Hepatol. 2010 Mar;25(3):519-25
pubmed: 20370730
Ann Surg Oncol. 2011 Sep;18(9):2469-76
pubmed: 21448750
Gastrointest Endosc. 2012 Apr;75(4):705-11
pubmed: 22440200
JAMA. 2014 Aug 13;312(6):606-15
pubmed: 25117129
J Natl Cancer Inst. 2017 Aug 1;109(8):
pubmed: 28376186
Clin Gastroenterol Hepatol. 2017 Jun;15(6):903-909.e6
pubmed: 27609707
Cancer. 2015 Jun 15;121(12):1912-3
pubmed: 26042851
Dis Colon Rectum. 2018 Aug;61(8):897-902
pubmed: 29771800
Nature. 2017 Aug 9;548(7666):E13-E14
pubmed: 28796214
JAMA Surg. 2015 Jan;150(1):17-22
pubmed: 25372703
N Engl J Med. 2012 Jun 21;366(25):2345-57
pubmed: 22612596
J Gastroenterol Hepatol. 2017 Jan;32(1):98-105
pubmed: 27197805
Mayo Clin Proc. 2014 Feb;89(2):216-24
pubmed: 24393412
World J Gastroenterol. 2016 Aug 28;22(32):7365-72
pubmed: 27621582
Dis Colon Rectum. 2015 Apr;58(4):388-92
pubmed: 25751794
Cancer. 2018 Jul 15;124(14):2964-2973
pubmed: 29846933
World J Gastroenterol. 2013 Sep 14;19(34):5651-7
pubmed: 24039357
J Natl Cancer Inst. 1997 Dec 3;89(23):1758-62
pubmed: 9392616
Int J Colorectal Dis. 2015 Apr;30(4):483-9
pubmed: 25707594
J Investig Med. 2017 Feb;65(2):311-315
pubmed: 27864324

Auteurs

Lior Segev (L)

Department of Colorectal Surgery, Cleveland Clinic Foundation, Cleveland, OH, USA. lior.segev@sheba.health.gov.il.
Department of Surgery C, Sheba Medical Center, 5265601, Tel HaShomer, Israel. lior.segev@sheba.health.gov.il.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. lior.segev@sheba.health.gov.il.

Matthew F Kalady (MF)

Department of Colorectal Surgery, Cleveland Clinic Foundation, Cleveland, OH, USA.

Thomas Plesec (T)

Department of Anatomic Pathology, Cleveland Clinic Foundation, Cleveland, OH, USA.

Eyal Mor (E)

Department of Surgery C, Sheba Medical Center, 5265601, Tel HaShomer, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Gal Schtrechman (G)

Department of Surgery C, Sheba Medical Center, 5265601, Tel HaShomer, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Aviram Nissan (A)

Department of Surgery C, Sheba Medical Center, 5265601, Tel HaShomer, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

James M Church (JM)

Department of Colorectal Surgery, Cleveland Clinic Foundation, Cleveland, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH